Myriam Armant

5PUBLICATIONS

47CO-AUTHORS

Molecular targetsChemical engineering designRegenerative medicine (incl. stem cells)Epigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 26, 2026

A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

|Mar 04, 2025

Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US.

Ula V Jurkunas, Aaron R Kaufman, Jia Yin

|Nov 17, 2023

Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.

Michael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu

|Sep 20, 2023

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.

Daniel C De Souza, Nicolas Hebert, Erica B Esrick

|Dec 15, 2022

Human genetic diversity alters off-target outcomes of therapeutic gene editing.

Samuele Cancellieri, Jing Zeng, Linda Yingqi Lin

Pageof 1

Frequent Collaborators

Samuele Cancellieri

Linda Yingqi Lin

Manuel Tognon

Shengdar Q Tsai

Scot A Wolfe

Rosalba Giugno

Daniel E Bauer

Luca Pinello

Christian Brendel

Giuseppe Di Caprio

Frequent Collaborators

Samuele Cancellieri

Linda Yingqi Lin

Manuel Tognon

Shengdar Q Tsai